Developing Clinical Trials for Oncology Part 3: Growth Trends in Oncology Therapeutics
Pharmaceuticals & Biotechnology Editor | 09/22/2011
More than ever clinical trials are more complicated and more difficult to run. Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his thoughts on the key drivers and innovations supporting growth in oncology therapeutics and the challenges around the corner. For the full interview go to Developing Clinical Trials for Oncology - Denis Mir, Eisai Global Clinical Development
To continue reading this story Click Here